Paudel, P.; Seong, S.H.; Wu, S.; Park, S.; Jung, H.A.; Choi, J.S.
Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D3/D4 Receptors. Mar. Drugs 2019, 17, 108.
https://doi.org/10.3390/md17020108
AMA Style
Paudel P, Seong SH, Wu S, Park S, Jung HA, Choi JS.
Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D3/D4 Receptors. Marine Drugs. 2019; 17(2):108.
https://doi.org/10.3390/md17020108
Chicago/Turabian Style
Paudel, Pradeep, Su Hui Seong, Sangwook Wu, Suhyun Park, Hyun Ah Jung, and Jae Sue Choi.
2019. "Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D3/D4 Receptors" Marine Drugs 17, no. 2: 108.
https://doi.org/10.3390/md17020108
APA Style
Paudel, P., Seong, S. H., Wu, S., Park, S., Jung, H. A., & Choi, J. S.
(2019). Eckol as a Potential Therapeutic against Neurodegenerative Diseases Targeting Dopamine D3/D4 Receptors. Marine Drugs, 17(2), 108.
https://doi.org/10.3390/md17020108